Ankylosing spondylitis places a large financial burden on the German healthcare system, especially the costs of certain medications and…
Articles by Joana Carvalho
While both Cosentyx (secukinumab) and nonsteroidal anti-inflammatory drugs (NSAIDs) have been found to reduce disease progression in…
People with non-radiographic axial spondyloarthritis share the same disease comorbidities as those affected by ankylosing spondylitis, which may hold implications…
A six-month course of treatment with Janssen‘s Simponi (golimumab) or Remicade (infliximab) significantly reduced the use of healthcare…
Patients with ankylosing spondylitis are more likely to develop venous thromboembolism — a condition in which a blood clot that…
Despite being rare, kidney complications should be considered in patients with ankylosing spondylitis treated with inhibitors of tumor necrosis factor-alpha…
While serum levels of sclerostin — a protein that regulates bone formation — are identical in patients with ankylosing spondylitis…
Emodin, a plant compound used in traditional Chinese medicine, has potent anti-inflammatory and anti-rheumatic properties that, when combined with…
Levels of a tiny RNA molecule, called miR-214, correlate with ankylosing spondylitis disease activity and may be used as…
Izana Bioscience has launched a proof-of-concept Phase 2 clinical study to assess the efficacy of namilumab in patients with…